المؤلفون: François Spertini, Wolfgang Pohl, Thomas Bieber, E. Hamelmann, Thilo Jakob, Karl Christian Bergmann, Mar Maurer, Petra Staubach, Wolfgang Schlenter, Ralph Mösges, Adam Chaker, Peter Schmid-Grendelmeier, Torsten Zuberbier, Regina Elisabeth Roller-Wirnsberger, Karin Hoffmann-Sommergruber, Holger Wrede, Roland Buhl, Claus Vogelmeier, Sven Becker, Friedrich Horak, Tilo Biedermann, Mübeccel Akdis, Ulf Darsow, Christian Taube, Hans F. Merk, Rudolf Valenta, P. Stute, Katja Nemat, Kirsten Jung, Jean Bousquet, Verena Niederberger-Leppin, Michael Gerstlauer, Christian Vogelberg, Jean-Pierre Michel, Thomas Werfel, R. Brehler, Wolfgang Czech, Jörg Kleine-Tebbe, Stefan Wöhrl, Paolo Maria Matricardi, Peter Valentin Tomazic, Joachim Saloga, Werner Aberer, Nikolai Khaltaev, Norbert Mülleneisen, Uta Rabe, Thomas Fuchs, Ludger Klimek, A. H. Fink-Wagner, O. Pfaar, Marek Jutel, Margitta Worm, J. Ring, Thomas Keil, Jeroen Buters, Wolfgang Wehrmann, Klaus Rabe, Isabella Pali-Schöll, Laurent P. Nicod, Susanne Lau, Martin Wagenmann, Otto Spranger, Cezmi A. Akdis

المصدر: Allergologie. 43:165-175

مصطلحات موضوعية: 2019-20 coronavirus outbreak, Allergen immunotherapy, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Virology, 030207 dermatology & venereal diseases, 03 medical and health sciences, Antiviral immunity, 0302 clinical medicine, 030228 respiratory system, Pandemic, Immunology and Allergy, Medicine, Position paper, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5efc9917a5c04ba7da4bad023268bfc8
https://doi.org/10.5414/alx02147